151 related articles for article (PubMed ID: 15846649)
21. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children.
Powell H; Gibson PG
Cochrane Database Syst Rev; 2004; 2004(2):CD004109. PubMed ID: 15106238
[TBL] [Abstract][Full Text] [Related]
22. Budesonide for chronic asthma in children and adults.
Adams N; Bestall J; Jones PW
Cochrane Database Syst Rev; 2001; 1999(4):CD003274. PubMed ID: 11687183
[TBL] [Abstract][Full Text] [Related]
23. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.
Manning P; Gibson PG; Lasserson TJ
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD007031. PubMed ID: 18425977
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
25. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
Cates CJ; Bestall J; Adams N
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001491. PubMed ID: 16437434
[TBL] [Abstract][Full Text] [Related]
26. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
27. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
29. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Cates CJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2008 Jul; (3):CD004106. PubMed ID: 18646100
[TBL] [Abstract][Full Text] [Related]
30. Budesonide at different doses for chronic asthma.
Adams N; Bestall J; Jones PW
Cochrane Database Syst Rev; 2001; 2000(4):CD003271. PubMed ID: 11687182
[TBL] [Abstract][Full Text] [Related]
31. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
Bleecker ER; Welch MJ; Weinstein SF; Kalberg C; Johnson M; Edwards L; Rickard KA
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1123-9. PubMed ID: 10856145
[TBL] [Abstract][Full Text] [Related]
32. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
33. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
Ng D; Salvio F; Hicks G
Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
[TBL] [Abstract][Full Text] [Related]
34. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
35. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma.
Westbroek J; Saarelainen S; Laher M; O'Brien J; Barnacle H; Efthimiou J
Respir Med; 1999 Oct; 93(10):689-99. PubMed ID: 10581657
[TBL] [Abstract][Full Text] [Related]
36. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
37. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
[TBL] [Abstract][Full Text] [Related]
38. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
39. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
